Cross-Tolerance of Oxyfluorfen-Tolerant Soybean Cells to Protoporphyrinogen Oxidase-Inhibiting Herbicides.

Bibliographic Information

Other Title
  • オキシフルオルフェン抵抗性ダイズ細胞のプロトポルフィリノーゲン酸化酵素阻害除草剤に対する交差抵抗性

Description

Characterization of cross-tolerance of selected oxyfluorfen-tolerant and non-selected (normal) soybean cell lines to protoporphyrinogen oxidase (Protox) inhibiting herbicides (oxyfluorfen, 2-chloro-1-(3-ethoxy-4-nitrophenoxy)-4-(trifluoromethyl) benzene; bifenox, methyl 5-(2, 4-dichloro-phenoxy)-2-nitrobenzoate; nitrofen, 2, 4-dichloro-1-(4-nitrophenoxy) benzene; and oxadiazon, 3-[2, 4-dichloro-5-(1-methylethoxy) phenyl]-5-(1, 1-dimethylethyl)-1, 3, 4-oxadiazol-2-(3H)-one) or acetolactate synthase (ALS) inhibiting herbicide (bensulfuron-methyl, methyl α-[[3-(4, 6-dimethoxypyrimidin-2-yl) ureido] sulfonyl]-o-toluate, BSM) was determined. The sensitivities of both cell types to oxyfluorfen were compared by determination of the growth rates and target enzyme inhibition using various Protox inhibiting herbicides. On the I50 values of growth, the tolerant cells showed about 100-, 200-, 5, 000-, and >30, 000-fold more tolerance than the normal cells to oxyfluorfen, oxadiazon, bifenox, and nitrofen, respectively. The cells were found to have cross-tolerance to all Protox inhibiting herbicides tested, however, a lack of cross-tolerance (<1.0) to BSM was observed. Determination of the inhibition on Protox activity showed that the sensitivity of the enzyme preparations between the two cell types differed about 15-fold to oxyfluorfen, 30-fold to oxadiazon, 45-fold to bifenox, and 100-fold to nitrofen. There was a positive correlation between the tolerance ratio determined by growth rate and that at the enzyme level.

Journal

Details 詳細情報について

  • CRID
    1390282679256496896
  • NII Article ID
    130003996177
  • DOI
    10.3719/weed.40.187
  • ISSN
    18824757
    0372798X
  • Text Lang
    en
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top